Publication:
Transition to ustekinumab in patients with moderate-to-severe psoriasis and inadequate response to methotrexate: a randomized clinical trial (TRANSIT)

Simple item page
dc.bibliographiccitation.firstpage425
dc.bibliographiccitation.issue2
dc.bibliographiccitation.journalBritish Journal of Dermatology
dc.bibliographiccitation.lastpage434
dc.bibliographiccitation.volume170
dc.contributor.authorPaul, C.
dc.contributor.authorPuig, Lluis
dc.contributor.authorKragballe, K.
dc.contributor.authorLuger, Thomas A.
dc.contributor.authorLambert, Jean-Charles
dc.contributor.authorChimenti, S.
dc.contributor.authorGirolomoni, G.
dc.contributor.authorNicolas, J.-F.
dc.contributor.authorRizova, E.
dc.contributor.authorLavie, F.
dc.contributor.authorMistry, S.
dc.contributor.authorBergmans, P.
dc.contributor.authorBarker, J.
dc.contributor.authorReich, Kristian
dc.date.accessioned2018-11-07T09:43:55Z
dc.date.available2018-11-07T09:43:55Z
dc.date.issued2014
dc.description.sponsorshipJanssen Pharmaceutica NV; Janssen
dc.identifier.isi000331358800027
dc.identifier.pmid24116959
dc.identifier.urihttps://resolver.sub.uni-goettingen.de/purl?gro-2/34282
dc.notes.statuszu prüfen
dc.notes.submitterNajko
dc.publisherWiley-blackwell
dc.relation.issn1365-2133
dc.relation.issn0007-0963
dc.titleTransition to ustekinumab in patients with moderate-to-severe psoriasis and inadequate response to methotrexate: a randomized clinical trial (TRANSIT)
dc.typejournal_article
dc.type.internalPublicationyes
dc.type.peerReviewedyes
dc.type.statuspublished
dspace.entity.typePublication

Files

Collections

Publications